Notice of Intent to Sole Source – Illumina
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) intends to award a sole source fixed-price purchase order to Illumina, Inc. for a maintenance agreement for the Illumina NextSeq 1000 Sequencing System at the NIH Clinical Center, Department of Transfusion Medicine (DTM) in Bethesda, MD. This is a notice of intent, not a request for quotation. Interested parties may identify their capabilities by May 10, 2026, 1600 EST.
Scope of Work
This acquisition covers a maintenance agreement for the Illumina NextSeq 1000 Sequencing System. The system is located at the Department of Transfusion Medicine (DTM) at the National Institutes of Health (NIH) Clinical Center (CC).
Contract & Timeline
- Type: Fixed-Price Purchase Order (Sole Source)
- Set-Aside: None (Sole Source under FAR Part 13.106-1(b)(1))
- NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
- Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
- Response Due: May 10, 2026, 1600 EST
- Published: May 4, 2026
- Place of Performance: Bethesda, MD 20892 USA
Evaluation
The NIH intends to award this contract to Illumina, Inc. on a sole source basis because Illumina is the original manufacturer and servicer of the equipment. This action is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which allows for soliciting from one source if only one is reasonably available. Responses from interested parties will be considered solely at the Government's discretion to determine if competition is viable.
Additional Notes
This is a notice of intent; a solicitation document will not be issued, and quotations will not be requested. Comments or statements of interest, referencing the posting number, should be submitted via email to Gregory Noland at gregory.noland@nih.gov.